JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 176 filers reported holding JUNO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.85 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,897,000 | +20.2% | 63,372 | +18.0% | 0.00% | 0.0% |
Q3 2017 | $2,410,000 | +84.3% | 53,724 | +22.8% | 0.00% | +50.0% |
Q2 2017 | $1,308,000 | +48.0% | 43,749 | +9.9% | 0.00% | +100.0% |
Q1 2017 | $884,000 | +122.1% | 39,826 | +88.6% | 0.00% | 0.0% |
Q4 2016 | $398,000 | -11.6% | 21,113 | +40.7% | 0.00% | 0.0% |
Q3 2016 | $450,000 | -6.2% | 15,004 | +20.2% | 0.00% | 0.0% |
Q2 2016 | $480,000 | +73.9% | 12,485 | +72.4% | 0.00% | – |
Q1 2016 | $276,000 | -50.6% | 7,240 | -43.0% | 0.00% | -100.0% |
Q4 2015 | $559,000 | +149.6% | 12,705 | +201.9% | 0.00% | – |
Q2 2015 | $224,000 | – | 4,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |